CYP19A1 and endometrial cancer: Recently, Sinreih et al. extended their studies on endometrial cancer steroid intracrinology and concluded that E2 was formed from E1S via the sulphatase pathway rather than via aromatase in endometrial cancer tissues (Sinreih et al. 2017).